Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation.
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2016
At a glance
- Drugs Ibutilide (Primary) ; Vernakalant (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 31 Mar 2016 Results published in a Cardiome Pharma media release.
- 31 Mar 2016 Results published online in the journal Europace, according to a Cardiome Pharma media release.
- 12 May 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.